Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
Kosuke EbinaYuki EtaniYuichi MaedaYasutaka OkitaMakoto HiraoWataru YamamotoMotomu HashimotoKoichi MurataRyota HaraKoji NagaiYuri HiramatsuYonsu SonHideki AmuroTakayuki FujiiTakaichi OkanoYo UedaMasaki KatayamaTadashi OkanoShotaro TachibanaTomoyuki KamenagaAtsushi KumanogohSeiji OkadaKen NakataPublished in: RMD open (2023)
TNFi (HR=1.52, 95% CI: 1.37 to 1.68) and CTLA4-Ig (HR=1.14, 95% CI: 1.00 to 1.30) showed a higher overall drug discontinuation rate, excluding non-toxicity and remission, than aIL-6R.